These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


223 related items for PubMed ID: 1848314

  • 21. The VBP and a1/EBP leucine zipper factors bind overlapping subsets of avian retroviral long terminal repeat CCAAT/enhancer elements.
    Smith CD, Baglia LA, Curristin SM, Ruddell A.
    J Virol; 1994 Oct; 68(10):6232-42. PubMed ID: 8083963
    [Abstract] [Full Text] [Related]

  • 22. Long terminal repeat regions from exogenous but not endogenous feline leukemia viruses transactivate cellular gene expression.
    Ghosh SK, Roy-Burman P, Faller DV.
    J Virol; 2000 Oct; 74(20):9742-8. PubMed ID: 11000248
    [Abstract] [Full Text] [Related]

  • 23. Nuclear factor 1 family members mediate repression of the BK virus late promoter.
    Kraus RJ, Shadley L, Mertz JE.
    Virology; 2001 Aug 15; 287(1):89-104. PubMed ID: 11504545
    [Abstract] [Full Text] [Related]

  • 24. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
    Pandey R, Ghosh AK, Kumar DV, Bachman BA, Shibata D, Roy-Burman P.
    J Virol; 1991 Dec 15; 65(12):6495-508. PubMed ID: 1658356
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ, Baglia LA, Ruddel A.
    J Virol; 1996 May 15; 70(5):3051-9. PubMed ID: 8627783
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.
    Ghosh SK, Faller DV.
    J Virol; 1999 Jun 15; 73(6):4931-40. PubMed ID: 10233955
    [Abstract] [Full Text] [Related]

  • 31. Human JC virus perfect palindromic nuclear factor 1-binding sequences important for glial cell-specific expression in differentiating embryonal carcinoma cells.
    Kumar KU, Pater A, Pater MM.
    J Virol; 1993 Jan 15; 67(1):572-6. PubMed ID: 8380093
    [Abstract] [Full Text] [Related]

  • 32. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor.
    Mink S, Härtig E, Jennewein P, Doppler W, Cato AC.
    Mol Cell Biol; 1992 Nov 15; 12(11):4906-18. PubMed ID: 1328867
    [Abstract] [Full Text] [Related]

  • 33. Nuclear factor 1 is a negative regulator of gadd153 gene expression in vascular smooth muscle cells.
    Nakamura M, Okura T, Kitami Y, Hiwada K.
    Hypertension; 2001 Feb 15; 37(2 Pt 2):419-24. PubMed ID: 11230311
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
    Thompson FJ, Elder J, Neil JC.
    J Gen Virol; 1994 Mar 15; 75 ( Pt 3)():545-54. PubMed ID: 8126451
    [Abstract] [Full Text] [Related]

  • 36. Nucleotide sequence of the envelope gene of Gardner-Arnstein feline leukemia virus B reveals unique sequence homologies with a murine mink cell focus-forming virus.
    Elder JH, Mullins JI.
    J Virol; 1983 Jun 15; 46(3):871-80. PubMed ID: 6304347
    [Abstract] [Full Text] [Related]

  • 37. An NF1-like protein functions as a repressor of the von Willebrand factor promoter.
    Jahroudi N, Ardekani AM, Greenberger JS.
    J Biol Chem; 1996 Aug 30; 271(35):21413-21. PubMed ID: 8702923
    [Abstract] [Full Text] [Related]

  • 38. Mutations that abrogate transactivational activity of the feline leukemia virus long terminal repeat do not affect virus replication.
    Abujamra AL, Faller DV, Ghosh SK.
    Virology; 2003 May 10; 309(2):294-305. PubMed ID: 12758176
    [Abstract] [Full Text] [Related]

  • 39. Evaluation of in vivo and in vitro interactions of feline immunodeficiency virus and feline leukemia virus.
    Beebe AM, Faith TG, Sparger EE, Torten M, Pedersen NC, Dandekar S.
    AIDS; 1994 Jul 10; 8(7):873-8. PubMed ID: 7946095
    [Abstract] [Full Text] [Related]

  • 40. Advances in understanding molecular determinants in FeLV pathology.
    Levy LS.
    Vet Immunol Immunopathol; 2008 May 15; 123(1-2):14-22. PubMed ID: 18289704
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.